This federal contract award to Hamilton Medical, Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the Medical Supply Chain division of the Defense agency for the delivery of HAMILTON-C3/C2/C1/T1/MR1 oxygen cells. The contract, valued at $6,314.46, is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and a completion date of March 11, 2025. The contract does not have a set-aside designation. Hamilton Medical, Inc. holds a significant Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract under the General Services Administration's Medical Equipment and Supplies Federal Supply Schedule 65-II-A, valued at $22.9 million and extending through December 2026, which has facilitated numerous task orders and delivery orders from agencies such as the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services.
Generated 3/12/25, 9:50 AM